RxDoctor Payments Data

Ryan Weiss

Physician Assistant · Bartlett, TNNPI 1932796737

Payments from drug & device makers

$1,250in general payments, 2019–2025

Across 38 payments — averaging $32.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cequr Corporation$284
  • Amgen$157
  • Novo Nordisk$108
  • AbbVie$93
  • Lilly USA, LLC$87
  • Dexcom, Inc.$83
  • plus $439 from 11 others

What the payments were for

  • Food & beverage$1,250100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,250 in reported general payments places this provider in the 70th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$44,146
Medicare patients
301
Services billed
1,385

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide30$34,350
MounjaroTirzepatide11$19,393
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$17,667
EliquisApixaban22$13,675
Albuterol Sulfate HfaAlbuterol Sulfate59$1,417
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav103$930
Methylprednisolone101$742
Atorvastatin Calcium45$524
Rosuvastatin Calcium66$515
Omeprazole37$474
Levothyroxine Sodium58$435
Ondansetron Hcl25$380
Fluticasone Propionate18$368
Doxycycline Hyclate48$356
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst29$337

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$108$34,35030 claims
Lilly USA, LLCMounjaro$87$19,39311 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$43558 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Bartlett

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →